Publication | Closed Access

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

Treatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral DrugHivMedicineHiv-infected Patients